田中 正美

業績
論文・著書名 掲載誌名
T r e a t m e n t f o r p a r a n e o p l a s t i cneuromyelitis optica spectrumdisorder (NMOsd): probable effects oftocilizumab for both cancer andNMOsd. Mult Scler Relat Disord, 2018;20:82-83.
I n t e r m i t t e n t d r u g h o l i d a y s i nfingolimod therapy for multiplesclerosis. Mult Scler 2018;24:236-7.
C o m p a r i s o n o f n a d i r s e r u m concentrations in the extended dosing therapy of natalizumab between American and Japanese multiple sclerosis patients. Mu lt S c ler J E x p Tr a n s C l i n 2016;2:2055217316642263.
Body weight based natalizumab treatment in adult patients with multiple sclerosis. J Neurol 262:781-2,2015
C o r t i c o s t e r o i d a n d t a c r o l i m u s treatment in neuromyelitis optica related disorders Mult Scler 21:669,2015
Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropenia. Mult Scler 19:1244-5,2013